臨床試驗

A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

NCT：NCT07788989 · NOT_YET_RECRUITING

NCT IDNCT07788989

狀態NOT_YET_RECRUITING

開始日期2026-10-30

完成時間2029-10-31

SponsorBiosense Webster, Inc. (INDUSTRY)

First posted2026-08-27

Last updated2026-09-15

簡要摘要

The purpose of this study is to evaluate how safe VARIPULSE™ Catheter is and how well it works in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF; irregular heartbeat where episodes start and stop on their own, usually within seven days) and symptomatic persistent atrial fibrillation (PsAF; irregular, rapid heartbeat that lasts more than 7 days and doesn't stop on its own).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。